Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-10-05, Stock:ABBV, The news for the past five days is as follows:
2020-09-28: NEWS1: AbbVie (ABBV) Gains But Lags Market: What You Should Know.NEWS2: BUZZ-U.S. STOCKS ON THE MOVE-Boeing, Bank of America, Eiger BioPharmaceuticals, Pangaea Logistics.NEWS3: BUZZ-U.S. STOCKS ON THE MOVE-Chesapeake Utilities, OpGen, Nikola, Perceptron.NEWS4: AbbVie: FDA Grants Orphan Drug & Fast Track Designations For Elezanumab .NEWS5: AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury.NEWS6: 3 Top Dividend Stocks With Yields Over 5%.
2020-09-29: NEWS1: AbbVie Elezanumab Gets FDA's Fast Track and Orphan Drug Tags.
2020-09-30: NEWS1: AbbVie withdraws uterine fibroids drug from Canada.NEWS2: US court voids $448 million award against AbbVie, AndroGel partner.NEWS3: U.S. court voids $448 million award against AbbVie, but revives FTC claim over AndroGel.NEWS4: US court voids $448 million award against AbbVie, AndroGel partner.NEWS5: Better Buy: CRISPR Therapeutics vs. Editas Medicine.NEWS6: Oxford to study anti-inflammatory drug Humira as potential COVID-19 treatment.
2020-10-01: NEWS1: After Hours Most Active for Oct 1, 2020 :  VICI, AAPL, SLB, ABBV, SGMS, MSFT, HST, MNST, APA, RUN, GE, VZ.NEWS2: Best ETFs for 2020: The AdvisorShares Vice ETF Saved by SAM and TMO.NEWS3: Stocks Are Expensive. These 14 Are Cheap and Could Grow..NEWS4: Cramer Gives His Opinion On AbbVie, Snowflake And More.NEWS5: 7 Dividend Stocks Perfect for a Retiree’s Portfolio.NEWS6: AbbVie: New Brunswick, British Columbia List SKYRIZI On Its Provincial Formulary .
2020-10-02: NEWS1: ABBV LONG TERM SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against AbbVie Inc. and Encourages Investors with Losses to Contact the Firm.NEWS2: AbbVie to Present New Data From 15 Abstracts at the 2020 Virtual Migraine Trust International Symposium.

Answer: Rise